Golden
RHEACELL

RHEACELL

Stem cell company manufacturing GMP-compliant limbal stem cells from cornea tissue that are ABCB5+, a marker associated with clinical success in transplantation of these cells for treating blindness.

RHEACEL is a subsidiary of TICEBA, developing human pharmaceuticals based on ABCB5+ mesenchymal stem cells. The company uses the GMP-compliant manufacturing process established by TICEBA to expand primary limbal stem cells from corneal tissue donors. Clinical trials using these cells are ongoing in Germany and the US. 

Timeline

People

Name
Role
LinkedIn







Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References